Inbrain Neuroelectronics is a Spanish neurotechnology company developing next-generation, graphene-based neuroelectronic therapies to treat neurological disorders such as Parkinson’s disease and epilepsy. Its end-to-end neural platform combines skin-like, high‑resolution brain–computer interfaces, an implantable neural processor with wireless rechargeable power, and an AI-powered personalization layer that decodes and modulates neural networks in real time. By leveraging graphene’s flexibility, signal fidelity, and high charge injection capacity, Inbrain aims to deliver minimally invasive, scalable, and patient-tailored neuromodulation therapies that improve function, mobility, and quality of life while reducing power consumption and enabling device miniaturization. The platform has received FDA Breakthrough Device Designation for use in Parkinson’s disease and is being developed in collaboration with leading research and industry partners.